Valuation: 3SBio Inc.

Market Cap 28.94B 33.97B 4.33B 3.87B 3.57B 3.24B 6.08B 411B 6.18B 43B 16.94B 215B 16.27B 15.92B 681B P/E 2026 *
12.6x
P/E 2027 * 11.9x
Enterprise Value 19.39B 22.77B 2.91B 2.59B 2.39B 2.17B 4.08B 275B 4.14B 28.82B 11.35B 144B 10.9B 10.67B 457B EV / Sales 2026 *
2.05x
EV / Sales 2027 * 1.69x
Free-Float
74.26%
Yield 2026 *
1.79%
Yield 2027 * 2.13%
1 day+3.15%
1 week-2.83%
Current month-15.15%
1 month-17.34%
3 months-19.98%
6 months-36.50%
Current year-41.85%
1 week 13.32
Extreme 13.32
15
1 month 13.32
Extreme 13.32
17
Current year 13.32
Extreme 13.32
29.3
1 year 13.32
Extreme 13.32
35.42
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2005
Director of Finance/CFO 43 02/07/2023
Corporate Officer/Principal 56 26/11/2014
Director TitleAgeSince
Chairman 63 02/04/2012
Director/Board Member 56 10/06/2012
Director/Board Member 57 31/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

490,000 0.0193%
29/07/25 Other

Chief Executive Officer

440,000 0.0184%
15/04/25 Other

Director

26,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%-2.83%-48.16%+122.12% 4.33B
-2.19%+1.91%+56.03%+122.16% 1,165B
-1.52%+2.86%+36.57%+73.63% 645B
-0.67%-0.81%+23.91%+95.41% 504B
+0.06%+3.45%+44.44%+65.14% 380B
-2.10%-1.49%+64.91%+39.11% 363B
-0.82%+2.73%+22.56%+51.60% 297B
-2.23%+2.65%+2.24%+26.50% 269B
-1.43%+2.10%+50.76%+61.71% 237B
-0.62%+0.15%+29.55%+101.68% 195B
Average -0.81%+1.78%+28.28%+75.90% 405.98B
Weighted average by Cap. -1.38%+3.16%+40.95%+82.34%

Financials

2026 *2027 *
Net sales 9.45B 11.09B 1.42B 1.26B 1.17B 1.06B 1.99B 134B 2.02B 14.04B 5.53B 70.25B 5.31B 5.2B 223B 9.77B 11.47B 1.46B 1.31B 1.21B 1.1B 2.05B 139B 2.09B 14.52B 5.72B 72.65B 5.5B 5.38B 230B
Net income 2.33B 2.74B 349M 312M 287M 261M 490M 33.07B 498M 3.46B 1.36B 17.33B 1.31B 1.28B 54.89B 2.49B 2.92B 373M 333M 307M 279M 524M 35.34B 532M 3.7B 1.46B 18.51B 1.4B 1.37B 58.65B
Net Debt -9.54B -11.2B -1.43B -1.28B -1.18B -1.07B -2.01B -135B -2.04B -14.18B -5.59B -70.94B -5.37B -5.25B -225B -12.41B -14.57B -1.86B -1.66B -1.53B -1.39B -2.61B -176B -2.65B -18.44B -7.26B -92.24B -6.98B -6.83B -292B
Projected Income Statement - Annual - 3SBio Inc.
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
23/10/26 HK$14.06 +3.15% 23,949,180
22/10/26 HK$13.63 -4.62% 26,781,994
21/10/26 HK$14.29 -2.79% 14,695,454
20/10/26 HK$14.70 +1.59% 14,601,232
16/10/26 HK$14.47 +0.77% 17,751,596
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - 3SBio Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
11.61CNY
Average target price
24.97CNY
Spread / Average Target
+115.08%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 3SBio Inc.
  1. Stock Market
  2. Stocks
  3. 1530 Stock